Home | Products | Tools | Technical Resource | Catalog Order | Custom Oligo Order |
Technical Sheet q Catalog No. 40-2002-10 Rh D 10 nmoles q Catalog No. 40-2003-10 Rh CcEe 10 nmoles
Shipped at ambient temperature. Store at -20oC |
|
Background
The Rh based blood grouping is
termed positive or negative based on the presence or absence of the D
antigen. Rh alloimmunization in Rh negative pregnant women is of concern
because of the potential for the fetus to develop hemolytic disease of
newborns and autoimmune diseases. Anemia leading to hydrops, perinatal
death, or both occurs in 25% of fetuses sensitized to the RhD antigen in
the absence of optimal management. In utero diagnosis and treatment
considerably improves the condition with survival rates greater than 75%
in severely affected fetuses. However these invasive therapies may be
unnecessary in some cases if the fetal Rh status were known
prenatally.
A method of determining fetal Rh status early in pregnancy is now possible by DNA analysis of amniotic cells (1). The Rh blood group locus consists of two related structural genes, D and CcEe. These highly homologous genes which share greater than 96% identity in their coding region have been cloned and the molecular basis of the Rh blood group established (2). The RhD-positive and RhD-negative polymorphism is associated with the presence or the absence of the D gene (there is no ‘d’ gene). The C/c and E/e antigens are encoded by a unique gene. The E/e associated nucleotide polymorphism results in one amino acid substitution at position 226 (proline to alanine), whereas the C/c antigenic polymorphism consists of six nucleotide substitutions leading to four amino acid changes at position 16 (Cys16Trp), 60 (Ile60Leu), 68 (Ser68Asn) and 103 (Ser103Pro). DNA analysis for Rh genotype loci specifically amplifies DNA fragments for the RhD and RhCcEe gene. Due to the high sensitivity and specificity of the test at the DNA level, occasionally the results may not match those obtained by serologic methods. The test will type individuals as RhD positive who are Du low grade status serologically (3-5), this is due to the absence of the gene product at the protein level due to partial deletions. The total error rate should be less than 1%. Material Supplied Two lyophilized oligonucleotide primers are supplied. Please refer to item number on the top of this sheet (Rh D or Rh EeCe Genemer>ä ). Each tube contains 10 nmoles of the primer. The quantity supplied is sufficient for 400 regular 50>m l PCR reaction. |
Reconstitution Stock solution : Add 50>m l sterile water to each tube containing the primer. The 10 nmoles of primer when dissolved in 50>m l water will give a solution of 200 >m Molar i.e. 200 pmoles/>m l.Primer Mix: Prepare a 10 pmoles/>m l Primer Mix solution containing BOTH the primers. Example; add 180 >m l water to a new tube. To this tube add 10 >m l of EACH of the primer stock solution from #1 step above. Label this tube as Primer Mix 10 pmoles/>m l.
Protocol for RhD and Rh EeCc Genotyping PCR reaction (100 >m l) Denaturation 94oC 30 sec. Annealing 49oC 1 min. Elongation 72oC 1 min. 30 cycles; 7 min. at 72oC, soak at 4oC. Precipitate products, dissolve in 10 >m l water, add 2 >m l loading buffer. ElectrophoresisLoad samples in a 1.8 % agarose gel or a 3% Nusieve agarose gel. Run at 90 mAmps for 2.5 hrs.
Results and Interpretation
RhD negative- 136 bp only;
Figure. Lane 1 is molecular weight markers. Lanes 2-4 represent PCR from a Rh D positive DNA and Lanes 5-7 represent PCR from Rh D negative DNA. Lanes 2, 5 & 7 PCR product of A1/A2 amplification, lanes 3 from A3/A4 amplification. Lane 4 is a multiplex of A1/A2 and A3/A4 amplification. |
Appendix
PCR
Premix preparation Typical Premix -----------------------------------------/50 >m l----rxn /1ml 10 x PCR Buffer ----------------___4.5 >m l___ 100>m l dNTP mix (2.5mM each) _________4 >m l___ 100>m l Primer Mix (10 pmol/>m l each) ___2.5 >m l____ 63>m l (25 pmol of each primer/50>m l) Sterile water _________________-34 >m l___ 737>m l ___________________________----------__-------- Total ________________________45 >m l____ 1ml Nucleotide
Dilution Total volume ________________________5.0ml |
Taq
Premix (per 50>m l reaction, scale up as
required) 10
x PCR Buffer ___________0.5>m l PCR reaction (50>m l) PCR products
post-processing |
Ordering Information
GENEMER>ä | |||
Product |
Size |
Catalog No. |
Price, $ |
Sickle Cell SC2/SC5 primer pair |
10nmoles |
40-2001-10 |
100.00 |
RhD (Rh D gene exon 10 specific) |
10nmoles |
40-2002-10 |
100.00 |
Rh EeCc (Rh Ee and Cc exon 7 specific) |
10nmoles |
40-2003-10 |
100.00 |
Fragile X (spanning triple repeat region) |
10nmoles |
40-2004-10 |
100.00 |
Gaucher 1226G mutation specific |
10nmoles |
40-2005-10 |
100.00 |
Gaucher 1448C mutation specific |
10nmoles |
40-2006-10 |
100.00 |
Gaucher 84GG mutation specific |
10nmoles |
40-2007-10 |
100.00 |
Gaucher IVS2 mutation specific |
10nmoles |
40-2008-10 |
100.00 |
Cystic Fibrosis >D F508 |
10nmoles |
40-2009-10 |
100.00 |
Cystic Fibrosis G542X |
10nmoles |
40-2010-10 |
100.00 |
Cystic Fibrosis W1282X |
10nmoles |
40-2011-10 |
100.00 |
Cystic Fibrosis G551D/R553X |
10nmoles |
40-2012-10 |
100.00 |
Cystic Fibrosis N1303K |
10nmoles |
40-2013-10 |
100.00 |
Cystic FibrosisCT3849 |
10nmoles |
40-2014-10 |
100.00 |
SRY (sex determining region on Y) |
10nmoles |
40-2020-10 |
100.00 |
X alphoid repeat |
10nmoles |
40-2021-10 |
100.00 |
Y alphoid repeat |
10nmoles |
40-2022-10 |
100.00 |
LINKMER>ä
LINKMER>ä are primer pairs for specific amplification of chromosomal sequences; specially suited for linkage analysis and chromosomal mapping. LINKMER>ä are supplied as lyophilized powder in aliquots of 10nmoles. The 10nmoles of primer when dissolved in 500>m l sterile water or TE will give a solution of 20>m Molar i.e. 20pmoles/>m l. The quantity supplied is sufficient for at least 400 regular 25>m l PCR reaction.
Product |
Size |
Catalog No. |
Price |
Please inquire, Linkmers>ä |
10nmoles |
$75.00 |
**The polymerase chain reaction (PCR) process is covered by patents owned by Hoffmann-La Roche. A license to perform is automatically granted by the use of authorized reagents.